Parthenon Capital-backed MRO completed the acquisition of Q-Centrix from TPG Growth.

Parthenon Capital-backed MRO, a clinical data exchange company in healthcare, completed the acquisition of Q-Centrix, an enterprise clinical data management platform, from TPG Growth, a middle market and growth equity platform. Financial terms were not disclosed. "At MRO, we believe there is tremendous untapped value in unlocking and leveraging clinical data that resides in fragmented, siloed systems today. Combining MRO's leading clinical data exchange solutions and Q-Centrix's clinical data management capabilities creates a category defining, fit for purpose platform, enabling high fidelity, low latency acquisition, abstraction, curation, and exchange of clinical data to power better patient care and reduce costs across the healthcare ecosystem," Jason Brown, MRO CEO.